1. Expression and characterization of albumin fusion protein canine IFNγ-CSA in baculovirus-insect cell expression system
- Author
-
Man-Lin Luo, Wu Jiajun, Anni Chen, Zou Shuzhan, Bu Wandi, Bing Li, Chen Ruiai, and Junqiong Zhai
- Subjects
0106 biological sciences ,Recombinant Fusion Proteins ,medicine.medical_treatment ,Serum albumin ,Gene Expression ,Sf9 ,Spodoptera ,Antiviral Agents ,01 natural sciences ,Vesicular stomatitis Indiana virus ,Interferon-gamma ,Mice ,03 medical and health sciences ,Dogs ,Pharmacokinetics ,010608 biotechnology ,Sf9 Cells ,medicine ,Animals ,Serum Albumin ,030304 developmental biology ,0303 health sciences ,biology ,Chemistry ,Albumin ,biology.organism_classification ,Fusion protein ,Molecular biology ,Cytokine ,Vesicular stomatitis virus ,biology.protein ,Female ,Baculoviridae ,Linker ,Biotechnology - Abstract
In this study, canine IFNγ was fused by a flexible linker with canine serum albumin to construct the fusion protein IFNγ-CSA for the purpose to design a long-acting canine IFNγ. The fusion protein was successfully expressed in baculovirus-infected Sf9 insect cells and was purified by salting-out and ion exchange chromatography. The IFNγ-CSA fusion possessed potent anti-viral assay against vesicular stomatitis virus in cultured cells. IFNγ-CSA was also stable at 37 °C up to 72 h compared with 8 h for IFNγ alone. In vivo pharmacokinetics demonstrated a significantly longer half-life for IFNγ-CSA (15.42 h) than for canine reIFNγ (1.51 h) in KM mice. These results indicate that IFNγ-CSA expression in the baculovirus system was successful and provide a promising long-acting cytokine for veterinary clinical applications.
- Published
- 2019
- Full Text
- View/download PDF